SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medi-Caps informs about updates

27 Feb 2023 Evaluate
Medi-Caps has informed that its Registrar and Share Transfer Agent Ankit Consultancy has duly completed the process of sending intimation via email on 10th February, 2023 to the Members of the Medicaps pertaining to SEBI Circular No. SEBI/HO/OIAE/2023/03391 dated January 27, 2023 read together with SEBI /HO/ MIRSD/MIRSD_RTAMB/P/CIR/2022/76 dated May 30, 2022 regarding availability of Dispute Resolution Mechanism at Stock Exchanges against Company/Registrar to an Issue and Share Transfer Agents (RTA). 

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

27.85 -1.63 (-5.53%)
08-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2674.75
BASF India 3340.85
Tata Chemicals 716.90
Pidilite Inds. 1459.00
Deepak Nitrite 1664.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×